Concepedia

Author

Roberta Pang

University of Hong Kong

Also Known As

Pang, Roberta, ROBERTA PANG, ROBERTA W.C. PANG, Roberta Pang, Roberta W. C. Pang, Roberta W. Pang, Roberta W.C. Pang, Roberta WC Pang

62

Publications

3.7K

Citations

29

H-Index

46

Concepts

All Affiliations

University of Hong KongQueen Mary HospitalChinese University of Hong KongRuttonjee HospitalHong Kong Sanatorium and Hospital
RP

About

Roberta Pang is an author at University of Hong Kong specializing in medicine, hepatocellular carcinoma, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

17

1.7K

2

Cell Biology

9

9

1K

3

Health Sciences

5

5

624

4

Gastroenterology

2

2

32

5

Natural Sciences

1

1

129

Roberta Pang

×

32

Publications

2.7K

Citations

23

H-Index

YearCitations

A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer

Roberta Pang, Wai Lun Law, Andrew Chu,

Cell stem cell

2010

536

A Phase I/II Trial of Chemoembolization for Hepatocellular Carcinoma Using a Novel Intra-Arterial Drug-Eluting Bead

Ronnie T.P. Poon, Wai Kuen Tso, Roberta Pang,

Clinical Gastroenterology and Hepatology

2007

288

Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection

Enders K. O. Ng, Rufina Li, Vivian Y. Shin,

PLoS ONE

2013

259

Significance of circulating endothelial progenitor cells in hepatocellular carcinoma†

Joanna W. Ho, Roberta Pang, Cecilia Lau,

Hepatology

2006

133

Pin1 Interacts With a Specific Serine-Proline Motif of Hepatitis B Virus X-Protein to Enhance Hepatocarcinogenesis

Roberta Pang, Terence K. Lee, Ronnie T. P. Poon,

Gastroenterology

2006

129

High Serum Vascular Endothelial Growth Factor Levels Predict Poor Prognosis after Radiofrequency Ablation of Hepatocellular Carcinoma: Importance of Tumor Biomarker in Ablative Therapies

Ronnie T.P. Poon, Cecilia Lau, Roberta Pang,

Annals of Surgical Oncology

2007

119

The Significance of Early Alpha-Fetoprotein Level Changes in Predicting Clinical and Survival Benefits in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib

Thomas Yau, Tzy‐Jyun Yao, Pierre Chan,

The Oncologist

2011

108

A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma

Thomas Yau, Paul N. Cheng, Pierre Chan,

Investigational New Drugs

2012

102

PIN1 overexpression and β-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma

Roberta Pang, John Yuen, Man‐Fung Yuen,

Oncogene

2004

99

Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma

Thomas Yau, Paul Cheng, Pierre Chan,

Investigational New Drugs

2015

79

Page 1